This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
這位Abbott分析師開始看好的報告; 以下是週二的前五個新規投資
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
華爾街頂級分析師改變了對這些頂級公司的展望。如需查看包括升級和降級在內的所有分析師評級變化的完整視圖，請參閱我們的分析師評級頁面。
- Oppenheimer analyst Suraj Kalia initiated coverage on Abbott Laboratories (NYSE:ABT) with an Outperform rating and announced a price target of $130. Abbott shares gained 0.6% to close at $113.36 on Monday. See how other analysts view this stock.
- Wells Fargo analyst Eva Fortea Verdejo initiated coverage on Arcus Biosciences, Inc. (NYSE:RCUS) with an Overweight rating and announced a price target of $29. Arcus Biosciences shares gained 3.9% to close at $17.30 on Monday. See how other analysts view this stock.
- Susquehanna analyst Charles Minervino initiated coverage on Howmet Aerospace Inc. (NYSE:HWM) with a Positive rating and announced a price target of $120. Howmet Aerospace shares gained 0.8% to close at $102.83 on Monday. See how other analysts view this stock.
- Morgan Stanley analyst Judah Frommer initiated coverage on Bicara Therapeutics Inc. (NASDAQ:BCAX) with an Overweight rating and announced a price target of $35. Bicara Therapeutics shares fell 2.8% to close at $24.45 on Monday. See how other analysts view this stock.
- Hovde Group initiated coverage on First National Corporation (NASDAQ:FXNC) with an Outperform rating and announced a price target of $22. First National shares gained 0.9% to close at $18.37 on Monday. See how other analysts view this stock.
- Oppenheimer分析師Suraj Kalia開始覆蓋雅培（紐交所：ABT），給予跑贏市場評級，並宣佈目標價爲130美元。週一雅培股票上漲0.6％，收於113.36美元。看看其他分析師如何看待這支股票。
- Wells Fargo分析師Eva Fortea Verdejo開始覆蓋arcus biosciences，公司（紐交所：RCUS），給予增持評級，並宣佈目標價爲29美元。週一Arcus Biosciences股票上漲3.9％，收於17.30美元。看看其他分析師如何看待這支股票。
- Susquehanna分析師Charles Minervino開始覆蓋howmet aerospace公司（紐交所：HWM），給予積極評級，並宣佈目標價爲120美元。週一howmet aerospace股票上漲0.8％，收於102.83美元。看看其他分析師如何看待這支股票。
- 摩根士丹利分析師Judah Frommer開始覆蓋Bicara Therapeutics公司（納斯達克：BCAX），給予增持評級，並宣佈目標價爲35美元。週一Bicara Therapeutics股票下跌2.8％，收於24.45美元。看看其他分析師如何看待這支股票。
- Hovde Group開始覆蓋first national公司（納斯達克：FXNC），給予跑贏市場評級並宣佈目標價爲22美元。週一first national股票上漲0.9％，收於18.37美元。看看其他分析師如何看待這支股票。
Considering buying ABT stock? Here's what analysts think:
考慮購買ABT股票嗎？以下是分析師的看法：
Read More:
閱讀更多：
- Dow Dips Around 400 Points As Treasury Yields Top 4%: Investor Optimism Declines, But Fear Index Remains In 'Greed' Zone
- 道指下跌約400點，美國國債收益率超過4%：投資者樂觀情緒下降，但恐懼指數仍處於'貪婪'區域
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。